Publications of H. Hermeking
All genres
Journal Article (35)
21.
Journal Article
18 (3), pp. 340 - 348 (2005)
Downregulation of 14-3-3 sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Modern Pathology 22.
Journal Article
124 (1), pp. IX - X (2005)
Extracellular 14-3-3 sigma protein: A potential mediator of epithelial-mesenchymal interactions. Journal of Investigative Dermatology 23.
Journal Article
23 (56), pp. 9034 - 9041 (2004)
Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression. Oncogene 24.
Journal Article
23 (36), pp. 6125 - 6135 (2004)
Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc. Oncogene 25.
Journal Article
50 (3 Suppl. Suppl. S), p. P127 - P127 (2004)
Loss of 14-3-3S expression in basal cell carcinoma by epigenetic si-lencing via CPG-methylation. Journal of the American Academy of Dermatology 26.
Journal Article
5, pp. 388 - 389 (2004)
Principles of Molecular Oncology. The Lancet Oncology 27.
Journal Article
3 (12), pp. 931 - 943 (2003)
The 14-3-3 cancer connection. Nature Reviews Cancer 28.
Journal Article
22 (35), pp. 5519 - 5524 (2003)
Analysis of 14-3-3 sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 29.
Journal Article
15 (1), pp. 44 - 49 (2003)
Serial analysis of gene expression and cancer. Current Opinion in Oncology 30.
Journal Article
3, pp. 163 - 175 (2003)
The c-MYC oncogene as a cancer drug target. Current Cancer Drug Targets 31.
Journal Article
110 (11), pp. 1717 - 1727 (2002)
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation 32.
Journal Article
62 (21), pp. 6255 - 6262 (2002)
Characterization of epithelial senescence by serial analysis of gene expression: Identification of genes potentially involved in prostate cancer. Cancer Research 33.
Journal Article
99 (9), pp. 6274 - 6279 (2002)
Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proceedings of the National Academy of Sciences of the United States of America 34.
Journal Article
15, pp. 44 - 49 (2002)
Serial analysis of gene expression and cancer. Current Opinion in Oncology 35.
Journal Article
110, pp. 1717 - 1727 (2002)
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. Journal of Clinical Investigation Book Chapter (1)
36.
Book Chapter
Cancer Drug Target Identification by SAGE, LongSAGE and Digital Karyotyping. In: The Applied Oncogenomics Handbook, pp. 19 - 30 (Eds. Shimkets, R. A.; LaRochelle, W. J.). Humana Press, Cancer Target Discovery and Development-Series, Totowa/USA (2005)
Thesis - Habilitation (1)
37.
Thesis - Habilitation
Identifizierung von Effektoren des p53 Tumorsuppressorgens und des c-MYC Onkogens sowie Untersuchungen zu epigenetischen Veränderungen und zellulärer Seneszenz in Tumoren. Habilitation, Ludwig-Maximilians-Universität, München (2006)